|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 142.14 USD | +0.72% |
|
+2.94% | +62.74% |
| 10-23 | UK approves J&J's oral psoriasis pill | RE |
| 10-12 | UBS Initiates Coverage on Protagonist Therapeutics With Buy Rating, $184 Price Target | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.72% | +2.94% | -0.21% | +3.87% | +62.74% | +81.05% | +909.52% | +339.11% | +622.62% | 9.13B | |
| +0.65% | -3.56% | -12.32% | +14.23% | +57.11% | +33.53% | +60.50% | +5.04% | - | 63.48B | |
| +1.76% | +1.27% | -5.68% | +3.19% | +11.13% | +11.82% | +81.21% | +231.09% | +5,462.85% | 54.55B | |
| -0.94% | +0.99% | +7.81% | +12.42% | +17.11% | +10.45% | +100.19% | -17.00% | +234.11% | 53.59B | |
| +2.76% | +0.87% | +2.98% | +14.86% | +23.79% | +27.92% | +55.07% | +8.50% | +288.80% | 44.75B | |
| +2.00% | -3.39% | +1.73% | +12.98% | +22.89% | +17.83% | +119.04% | +2.41% | +1,015.51% | 41.62B | |
| +1.34% | -2.86% | -6.45% | +2.64% | +136.94% | +224.43% | +914.08% | +534.35% | - | 39.91B | |
| +0.64% | -3.95% | +6.45% | +6.99% | +10.10% | +11.15% | +45.57% | +7.13% | +158.47% | 32.47B | |
| +29.06% | +47.63% | +68.03% | +102.73% | +90.82% | +107.12% | +92.73% | +36.25% | +242.30% | 26.7B | |
| +3.72% | -6.23% | -13.26% | +20.06% | +47.33% | +26.01% | -2.99% | -59.79% | - | 23.36B | |
| +1.07% | -3.61% | -11.19% | -4.82% | -7.57% | -16.22% | -3.52% | -69.02% | - | 21.87B | |
| +2.13% | +3.13% | -17.58% | -6.87% | -44.28% | -41.33% | +306.11% | +227.75% | +616.25% | 20.74B | |
| +2.80% | +4.56% | +12.46% | +21.32% | +23.33% | +19.32% | +176.76% | +215.27% | +2,297.65% | 18.85B | |
| +4.22% | +8.44% | +26.95% | +55.55% | +87.48% | +99.00% | +116.69% | -14.77% | +392.08% | 17.13B | |
| +0.89% | +6.60% | +9.55% | +25.86% | +38.21% | +41.38% | +86.34% | -16.19% | +110.21% | 16.53B | |
| +1.42% | +2.63% | +13.55% | +17.29% | +51.22% | +65.39% | +228.12% | +204.60% | +509.19% | 16.19B | |
| +1.50% | +4.46% | +8.48% | -1.92% | - | - | - | - | - | 16.15B | |
| +0.84% | +2.13% | +3.90% | +7.62% | +183.22% | +166.23% | +345.61% | +1,427.61% | +795.27% | 15.21B | |
| -4.32% | -8.37% | -4.75% | -14.73% | +10.56% | +2.80% | +463.48% | - | - | 13.81B | |
| +17.04% | +15.61% | +21.98% | +18.82% | +17.53% | +20.50% | -8.99% | -25.23% | +166.63% | 14.12B | |
| Average | +3.46% | +1.78% | +5.62% | +15.60% | +44.19% | +47.81% | +215.03% | +168.73% | +922.28% | 28.01B | |
| Weighted average by Cap. | +3.01% | +0.92% | +3.38% | +15.15% | +41.47% | +44.67% | +180.12% | +128.52% | +1,232.59% |
- Stock Market
- Stocks
- PTGX Stock
- Sector Protagonist Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
